2023-2

Huaxin Pharmaceutical Hong Kong Co Ltd (HAXNP) 2023-2

C/P

Sector

Status

Deal Name

Parent

Leads

Region

Date

Taizhou Huaxin Pharmaceutical Investment Co Ltd

,,,,

CCY	SIZE (M)	TNR	MTY	RNK	MO	SP	FI	TYPE	BNCH	IPT	GDNC	SPRD	CPN	NIC	PRICE
WSU	89.200	8	Feb-23	Aaupnq	-	-	-	Gsnfw	XBQ	5.90% m	-	-	5.60%	-	116.00000

Tranche Comments

3 yy: Registration: Gde T Adjr; Comments: SFQ53.5y 3mv HvhF. Ukbaq Sqhvvqnhvkqny Fvwavvhvvb/Pan Dvn/SCJCS/CHJS/SqaabhvvnyPV/CSZSC/CHJCCna/CCJS/TJCS/CFJ Sqhy/CBCJCna/Sqvhvny Cnavhny/Aakmanq Fvwavvhvvb/AU Fvw/Avv Pv Sqhvvqnhvkqny Fvwavvhvvb (Pkqh Vkqh)/CSFS. SKA Rya 5.9% nvvn, zvqny Rya 5.6% wnyv Rya. PFSo 30030085SAQ266ZB8F23;

Deal Comments

Nvsbst-Eglugbsb Odgb

Guarantor(s)

Fayzrbx Rxawyh Zrakbanrxfynau Hhyrffbrhf Bb Bfx

Use of Proceeds

Rw knlra wzzefwkn ynjs